Vorinostat is a Potential Precipitant for Severe Gastrointestinal Toxicity

Abstract

Get full access to this article

View all access options for this article.

References

de Haan

, van den Berg

Colonic perforation secondary to Taxol therapy: an unusual presentation.

Onkologie 2006; 29: 541–2.

Modesitt

S.C.

, Sill

, Hoffman

J.S.

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gynecol Oncol 2008; 109: 182–6.

Muraoka

, Tsukuda

, Toyooka

Ileal perforation induced by acute radiation injury under gefitinib treatment.

Int J Clin Oncol 2011; 16: 774–7.

Cannistra

S.A.

, Matulonis

U.A.

, Penson

R.T.

A Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.

J Clin Oncol 2007; 25: 5180–6.